CPPCY yields 3.14% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, CPPCY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CPPCY + JNJ for your $10,000?
CP ALL Public Company Limited, together with its subsidiaries, operates and franchises convenience stores under the 7-Eleven name to other retailers primarily in Thailand. It operates through three segments: Wholesale Business, Retail Business, and Management of Rental Spaces in Shopping Centers. The Wholesale Business segment engages in import, export, and distribution of frozen and chilled food with delivery services and focuses on selling consumer products, including fresh food, dry food, and consumer products under Makro brand. Its Retail Business segment is involved in domestic supply chain, distribution system, logistics network, and brand equity businesses. This segment also sells its products under various domestic, international, and small and medium enterprises brands. The company's Management of Rental Spaces in Shopping Centers segment manages buildings and retail spaces in shopping malls. In addition, the company is involved in sale and maintenance of retail equipment; cash and carry, catalog, and e-commerce businesses; marketing and advertising activities; provision of information technology and research and development services, as well as engaged in bill payment collection, life insurance, and non-life insurance broker business. Further, the company offers educational institution, training, business seminar services, as well as healthcare and medical specialist's consultation services. As of December 31, 2021, CP ALL Public Company Limited operated 13,134 stores. The company was formerly known as C.P. Seven Eleven Public Company Limited. CP ALL Public Company Limited was founded in 1988 and is headquartered in Bangkok, Thailand.
Full CPPCY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.